Zhengchao Wen
YOU?
Author Swipe
View article: Comprehensive characterization of long <scp>QT</scp> syndrome‐associated genes in cancer and development of a robust prognosis model
Comprehensive characterization of long <span>QT</span> syndrome‐associated genes in cancer and development of a robust prognosis model Open
Cancer is the leading public health problem worldwide. However, the side effects accompanying anti‐cancer therapies, particularly those pertaining to cardiotoxicity and adverse cardiac events, have been the hindrances to treatment progress…
View article: Identification of adipokine-related gene-based molecular subtypes of colon cancer and prognostic characteristics
Identification of adipokine-related gene-based molecular subtypes of colon cancer and prognostic characteristics Open
View article: An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications Open
View article: Machine-learning Approach to Reveal a Novel Hepatic Stellate Cell-based Classification for Prognostic Prediction in Patients with Hepatocellular Carcinoma
Machine-learning Approach to Reveal a Novel Hepatic Stellate Cell-based Classification for Prognostic Prediction in Patients with Hepatocellular Carcinoma Open
Background: Hepatocellular carcinoma (HCC) is one of the major concerns regarding public health globally. Cancer-associated fibroblasts (CAFs) play a vital role in HCC progression. The identification of CAF-associated HCC subtypes and the …
View article: Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy
Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy Open
Background: Anti-programmed cell death 1/programmed cell death ligand 1 (PD1/PDL1) therapy is an important part of comprehensive cancer therapy. However, many patients suffer from non-response to therapy. Tumor neoantigen burden (TNB) and …